Relx NV (ADR)  

(Public, NYSE:RENX)   Watch this stock  
Find more results for NYSE:ENL
+0.11 (0.64%)
Real-time:   11:30AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 17.37 - 17.49
52 week 14.80 - 51.81
Open 17.48
Vol / Avg. 28,446.00/124,777.00
Mkt cap 38.50B
P/E 29.87
Div/yield 0.13/2.54
EPS 0.58
Shares 1.00B
Beta 1.03
Inst. own 1%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 17.20% 16.62%
Operating margin 24.09% 24.28%
EBITD margin - 29.14%
Return on average assets 47.33% 40.82%
Return on average equity 49.32% 42.39%
CDP Score - -


Radarweg 29
+31-20-4852222 (Phone)
+31-20-4852032 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


RELX NV, formerly known as Reed Elsevier NV, is a company based in the Netherlands which provides information solutions for customers across industries. Its products and services comprise intellectual property content delivered through various media, including online, journals and books. The Company operates in four market segments: Scientific, Technical & Medical; Risk & Business Information; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and tools to help customers improve scientific and healthcare outcomes. The Risk & Business Information segment provides data and analytics that enable customers to evaluate and manage risk. The Legal segment provides legal, regulatory, news, business information and analysis to legal, corporate, Government and academic customers. The Exhibitions segment, through the subsidiary Reed Exhibitions, organizes market events relevant to industry needs. The Company operates in North America and Europe.

Officers and directors

Erik Engstrom Chief Executive Officer, Executive Director
Age: 51
Bio & Compensation  - Reuters
Nick L. Luff Chief Financial Officer, Executive Director
Age: 47
Bio & Compensation  - Reuters
Mark Kelsey Chief Executive Officer Risk Solutions and Business Information
Bio & Compensation  - Reuters
Ron Mobed Chief Executive Officer Scientific, Technical and Medical
Age: 55
Bio & Compensation  - Reuters
Mike Rusbridge Chief Executive Officer Exhibitions
Bio & Compensation  - Reuters
Mike Walsh Chief Executive Officer Legal
Bio & Compensation  - Reuters
Henry Adam Udow Chief Legal Officer and Company Secretary
Bio & Compensation  - Reuters
Ian Fraser Human Resources Director
Bio & Compensation  - Reuters
Kumsal Bayazit Chief Strategy Officer
Bio & Compensation  - Reuters
Youngsuk Chi Director of Corporate Affairs and Chairman Elsevier
Bio & Compensation  - Reuters